Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. In 2020, based on application, the others segment accounted for the largest revenue share. Opportunity Analysis (2014-2020-2028). PESTLE Analysis.

Cannabinoids 40

Cannabinoids Clinical Trials Research and Development Supply Chain 40

Cannabis Law Report

SEPTEMBER 6, 2021

The global medical cannabis market exhibited strong growth during 2015-2020. Clinical trials, research and development (R&D) activities and commercialization of cannabis-based indications are further expected to catalyze the growth of the market. during 2021-2026. Companies Mentioned. Canopy Growth Corporation. Chronic Pain.

Chronic Pain 66

Chronic Pain Research and Development Clinical Trials Epilepsy 66

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Key Priorities for 2020.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Epilepsy & behavior case reports 9 (2018): 10. The Journal of Clinical Pharmacology 60.4 2020): 432-438. Alsherbiny, Muhammad, and Chun Li. Medicines 6.1

CBD 98

CBD THC Conditions Medicine 98

Puff Puff Post

JANUARY 1, 2020

Sativex is a cannabinoid medication prescribed to cancer patients and individuals suffering from epilepsy and other muscle disorders. National legalisation of medical cannabis could occur as early as 2020 in Spain. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain.

Treatment 49

Treatment Clinical Trials Research and Development Cannabinoids 49

Canna Care Docs

DECEMBER 16, 2020

Between the pandemic and the political climate, 2020 hasn’t exactly been a walk in the park. Cannabis appears to have strong benefits for people struggling with epilepsy, with a 2015 study finding a 54% reduction in seizures for patients who were not helped by other treatments. Chronic pain.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

SEPTEMBER 1, 2019

The Victorian and New South Wales Governments had both begun clinical trials of cannabis products for children with severe epilepsy and for palliative care, respectively. The clinical trials and the standard of production could lead the world.”. Source: [link].

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

The Cannigma

AUGUST 26, 2021

percent), according to the United Nations World Drug Report for 2020.In In addition, a survey published in July 2020 found that 41% of Australians support cannabis legalization, and 37% are opposed. percent) remains far higher than the world average (3.9 This represents nearly double the level of support found in a 2007 survey (21%).

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

NOVEMBER 15, 2021

Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. FINANCIAL RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020. On September 9, 2021, Jeffrey A.

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

OCTOBER 26, 2021

MyMD plans to advance MYMD-1 in the clinic with two simultaneous Phase 2 trials beginning in the current quarter, one for delaying aging and prolonging healthy lifespan, and the second for COVID-19-associated depression and cytokine elevation. Dr. Chapman Bio. Chapman has operated Chapman Pharmaceutical Consulting, Inc.,

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

The Joint Blog

FEBRUARY 24, 2021

Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This is not the first medicinal trial of its kind. Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s?

Treatment 55

Treatment Clinical Trials Collective Patients 55

Puff Puff Post

JANUARY 1, 2020

Sativex is a cannabinoid medication prescribed to cancer patients and individuals suffering from epilepsy and other muscle disorders. National legalisation of medical cannabis could occur as early as 2020 in Spain. Nabiximol is a cannnabis derived drug that exited clinical trials in Spain.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Cannabis Law Report

DECEMBER 7, 2021

The search included studies through 11-May-2020. This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. The search included published and unpublished studies through 11-May-2020.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

NOVEMBER 10, 2021

IND-enabling studies for Envelta are being performed under a Cooperative Research and Development Agreement (CRADA) with NCATS entered into by Virpax in August of 2020. “We Envelta is Virpax’s endogenous enkephalin intranasal spray for acute and chronic pain, including pain associated with cancer. Forward-Looking Statement.

Research and Development 40

Research and Development Chronic Pain Pharmaceutical Clinical Trials 40

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Epilepsy & behavior case reports 9 (2018): 10. [4] The Journal of Clinical Pharmacology 60.4 2020): 432-438. [6] Drug metabolism reviews 46.1

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. The Office of Drug Control (ODC) (ODC 2020 ), alongside the Therapeutic Goods Administration (TGA), regulates the production of cannabis and cannabis products.

Research and Development 52

Research and Development Medicine Access Media 52

Veriheal

AUGUST 31, 2020

It brings us great pleasure to present the 10 winners of Veriheal’s Innovation in Cannabis Scholarship 2020. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . The post Veriheal’s Innovation in Cannabis Scholarship 2020 Winners appeared first on Cannabis Central. Nishtha Tripathi. School: George Washington University.

Research and Development 119

Research and Development Education Agriculture Patients 119

Cannabis Law Report

DECEMBER 18, 2019

Notably, the increase comes after the company recently broke into the European pharma-market after getting green-lighted from the Irish Government to sell its phytocannabinoid-derived “CannEpil” product to epilepsy sufferers. Both products are proprietary medicinal drugs developed internally through MGC’s research and development divisions.

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59

Cannabis Law Report

DECEMBER 30, 2019

After this historically successful year, we expect to see public and political support continue to increase in 2020 as more and more states implement sensible cannabis regulatory policies. A House floor vote on HR 3884 is anticipated in 2020. FY 2020 Successful House Appropriations Advancements. Erik Altieri.

Legislation 45

Legislation Patients Access Banking 45

SMPL

MAY 26, 2020

But the CBD landscape of 2020 looks nothing like what the activists and scientists intended. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex. There haven’t been enough clinical trials and there never will be,” said Mr. Clarke, the cannabis seed collector.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. There’s the one drug, one target, cannabis is multiple active ingredients and acts on multiple targets in the body.

Legalization 132

Legalization Patients Education Dispensary 132

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. This is true even if the CBD comes from industrial hemp.

Law 40

Law Seed-To-Sale Hemp Recreational 40